Evidence map›Paper›PMID 23230464›Full record

ReviewJournal of preventive medicine and public health = Yebang Uihakhoe chi2012

Human exposure and health effects of inorganic and elemental mercury.

Jung-Duck Park, Wei Zheng

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Journal of preventive medicine and public health = Yebang Uihakhoe chi, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04183595 (A Double-blinded, Randomized Controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of N1, N3-bis-), which is not on this map. Cited by 213 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
213citing papers in PubMed, 6 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04183595 phase2 / phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

A Double-blinded, Randomized Controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of N1, N3-bis-(2-Mercaptoethyl) Isophthalamide (NBMI) in the Reduction of Mercury Levels, in Subjects Exposed to Mercury in Colombia

TypeinterventionalSponsorEmeraMedRan2023 to 2024Enrolled116ConditionsMercury PoisoningArms(N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose, silica and magnesium stearate
3 · Its place in the literature

Who cites it

213 citing papers in PubMed, 6 syntheses or guidelines pooled it, 739 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Contamination of breast milk with lead, mercury, arsenic, and cadmium in Iran: a systematic review and meta-analysis.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2022
    Pooled it
  6. Chronic mercury exposure and blood pressure in children and adolescents: a systematic review.Environmental science and pollution research international · 2019
    Pooled it
  7. The Protective Effect ofPlants (Basel, Switzerland) · 2026
    Article
  8. Review
  9. Mercury in skin lightening and skin care products purchased in New York City, 2009-2022.Journal of exposure science & environmental epidemiology · 2026
    Article
  10. Article
  11. Review
  12. Panitumumab labeled with Auger electron-emittingEJNMMI radiopharmacy and chemistry · 2026
    Article
  13. Mercury-induced excitotoxicity in autism spectrum disorder: disruption of glutamatergic homeostasis and the therapeutic role of the selenium-glutathione axis.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

153 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Jung-Duck ParkDepartment of Preventive Medicine, College of Medicine, Chung-Ang University, Seoul, Korea. jdpark@cau.ac.kr
Wei Zheng
Chung-Ang University · KRPurdue University West Lafayette · US

Funding

Choroid Plexus a Target in Metal-Induced NeurotoxicityR01ES008146 · NIEHS · PURDUE UNIVERSITY WEST LAFAYETTE · PI ZHENG, WEI · 1998 to 2014
$5.0M
NIEHS NIH HHS R01 ES008146
6 · The paper itself

Abstract

Mercury is a toxic and non-essential metal in the human body. Mercury is ubiquitously distributed in the environment, present in natural products, and exists extensively in items encountered in daily life. There are three forms of mercury, i.e., elemental (or metallic) mercury, inorganic mercury compounds, and organic mercury compounds. This review examines the toxicity of elemental mercury and inorganic mercury compounds. Inorganic mercury compounds are water soluble with a bioavailability of 7% to 15% after ingestion; they are also irritants and cause gastrointestinal symptoms. Upon entering the body, inorganic mercury compounds are accumulated mainly in the kidneys and produce kidney damage. In contrast, human exposure to elemental mercury is mainly by inhalation, followed by rapid absorption and distribution in all major organs. Elemental mercury from ingestion is poorly absorbed with a bioavailability of less than 0.01%. The primary target organs of elemental mercury are the brain and kidney. Elemental mercury is lipid soluble and can cross the blood-brain barrier, while inorganic mercury compounds are not lipid soluble, rendering them unable to cross the blood-brain barrier. Elemental mercury may also enter the brain from the nasal cavity through the olfactory pathway. The blood mercury is a useful biomarker after short-term and high-level exposure, whereas the urine mercury is the ideal biomarker for long-term exposure to both elemental and inorganic mercury, and also as a good indicator of body burden. This review discusses the common sources of mercury exposure, skin lightening products containing mercury and mercury release from dental amalgam filling, two issues that happen in daily life, bear significant public health importance, and yet undergo extensive debate on their safety.

Indexed as

Environmental ExposureBiological AvailabilityBiomarkersBlood-Brain BarrierBody BurdenDental AmalgamHumansMercuryMercury CompoundsSkin Lightening PreparationsBiomarkersDental AmalgamMercuryMercury CompoundsSkin Lightening PreparationsBiomarkersBrainElemental mercuryInorganic mercury compoundsKidneyPublic health

Identifiers

PMID23230464
PMCPMC3514464
OpenAlexW2011998213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.